[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fDYjH8IRu0WY69pQUOwv1CppcW9HC7PPcVDAZa3v2F4I":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":45,"rows":52},"University of Chile",[4],179,false,22,12,666931,3,139,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"Pain, Postoperative",8,{"name":18,"count":19},"Depression",7,{"name":21,"count":22},"Stroke",6,{"name":24,"count":22},"Obesity",{"name":26,"count":27},"Periodontitis",5,{"name":29,"count":27},"Analgesia",{"name":31,"count":27},"Covid19",{"name":33,"count":27},"Critical Illness",[35,40],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06237101","Remifentanil Effect on Burst Suppression Ratio","2026-08-31","High dose of remifentanil",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06662526","Lithium for Prevention of Cognitive Declining in Mood Illnesses","2029-11-01","Trace lithium dose plus treatment as usual",[46,47,48,49,50,51],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[53,81,107,125,155,173,191,209,237,265,291,317,342,367,394,412,437,463,481,518,543,568,591,609,633,659,683,706,731,756,784,809,827,854,880,911,929,954,981,1019,1047,1072,1097,1115,1133,1158,1182,1200,1223,1250,1268],{"intervention":44,"totalTrials":54,"cells":55},1,{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":65,"NA":79},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":58},[],{"trials":64,"activeCount":58},[],{"trials":66,"activeCount":54,"soonestReadout":43},[67],{"nctId":41,"briefTitle":42,"status":68,"phases":69,"primaryCompletion":43,"completion":70,"start":71,"enrollment":72,"conditions":73,"interventions":78},"NOT_YET_RECRUITING",[50],"2030-11-01","2024-11-01",250,[74,75,76,77],"Dementia","Bipolar Disorder (BD)","Depression - Major Depressive Disorder","Mild Cognitive Impairment (MCI)",[44],{"trials":80,"activeCount":58},[],{"intervention":39,"totalTrials":54,"cells":82},{"EARLY_PHASE1":83,"PHASE1":85,"PHASE2":87,"PHASE3":89,"PHASE4":91,"NA":93},{"trials":84,"activeCount":58},[],{"trials":86,"activeCount":58},[],{"trials":88,"activeCount":58},[],{"trials":90,"activeCount":58},[],{"trials":92,"activeCount":58},[],{"trials":94,"activeCount":54,"soonestReadout":38},[95],{"nctId":36,"briefTitle":37,"status":96,"phases":97,"primaryCompletion":38,"completion":98,"start":99,"enrollment":100,"conditions":101,"interventions":105},"RECRUITING",[51],"2026-09-30","2024-03-01",20,[102,103,104],"Anesthesia, Intravenous","Electroencephalography","Burst Suppression",[39,106],"Medium dose of remifentanil",{"intervention":106,"totalTrials":54,"cells":108},{"EARLY_PHASE1":109,"PHASE1":111,"PHASE2":113,"PHASE3":115,"PHASE4":117,"NA":119},{"trials":110,"activeCount":58},[],{"trials":112,"activeCount":58},[],{"trials":114,"activeCount":58},[],{"trials":116,"activeCount":58},[],{"trials":118,"activeCount":58},[],{"trials":120,"activeCount":54,"soonestReadout":38},[121],{"nctId":36,"briefTitle":37,"status":96,"phases":122,"primaryCompletion":38,"completion":98,"start":99,"enrollment":100,"conditions":123,"interventions":124},[51],[102,103,104],[39,106],{"intervention":126,"totalTrials":54,"cells":127},"IPV",{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":136,"NA":153},{"trials":129,"activeCount":58},[],{"trials":131,"activeCount":58},[],{"trials":133,"activeCount":58},[],{"trials":135,"activeCount":58},[],{"trials":137,"activeCount":58},[138],{"nctId":139,"briefTitle":140,"status":141,"phases":142,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":147,"interventions":149},"NCT01841671","Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine","UNKNOWN",[50],"2014-05","2014-06","2013-04",570,[148],"Polio",[126,150,151,152],"bOPV","mOPV type 2","Rotarix",{"trials":154,"activeCount":58},[],{"intervention":150,"totalTrials":54,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":171},{"trials":158,"activeCount":58},[],{"trials":160,"activeCount":58},[],{"trials":162,"activeCount":58},[],{"trials":164,"activeCount":58},[],{"trials":166,"activeCount":58},[167],{"nctId":139,"briefTitle":140,"status":141,"phases":168,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":169,"interventions":170},[50],[148],[126,150,151,152],{"trials":172,"activeCount":58},[],{"intervention":151,"totalTrials":54,"cells":174},{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":189},{"trials":176,"activeCount":58},[],{"trials":178,"activeCount":58},[],{"trials":180,"activeCount":58},[],{"trials":182,"activeCount":58},[],{"trials":184,"activeCount":58},[185],{"nctId":139,"briefTitle":140,"status":141,"phases":186,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":187,"interventions":188},[50],[148],[126,150,151,152],{"trials":190,"activeCount":58},[],{"intervention":152,"totalTrials":54,"cells":192},{"EARLY_PHASE1":193,"PHASE1":195,"PHASE2":197,"PHASE3":199,"PHASE4":201,"NA":207},{"trials":194,"activeCount":58},[],{"trials":196,"activeCount":58},[],{"trials":198,"activeCount":58},[],{"trials":200,"activeCount":58},[],{"trials":202,"activeCount":58},[203],{"nctId":139,"briefTitle":140,"status":141,"phases":204,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":205,"interventions":206},[50],[148],[126,150,151,152],{"trials":208,"activeCount":58},[],{"intervention":210,"totalTrials":54,"cells":211},"Administration of Metronidazole plus Amoxicillin",{"EARLY_PHASE1":212,"PHASE1":214,"PHASE2":216,"PHASE3":218,"PHASE4":220,"NA":235},{"trials":213,"activeCount":58},[],{"trials":215,"activeCount":58},[],{"trials":217,"activeCount":58},[],{"trials":219,"activeCount":58},[],{"trials":221,"activeCount":58},[222],{"nctId":223,"briefTitle":224,"status":225,"phases":226,"primaryCompletion":227,"completion":228,"start":229,"enrollment":230,"conditions":231,"interventions":234},"NCT01211223","Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis.","COMPLETED",[50],"2011-03","2014-03","2010-01",42,[232,233],"Chronic Periodontitis","Clinical and Microbiological Effects",[210],{"trials":236,"activeCount":58},[],{"intervention":238,"totalTrials":54,"cells":239},"Intravenous study drug",{"EARLY_PHASE1":240,"PHASE1":242,"PHASE2":244,"PHASE3":246,"PHASE4":248,"NA":263},{"trials":241,"activeCount":58},[],{"trials":243,"activeCount":58},[],{"trials":245,"activeCount":58},[],{"trials":247,"activeCount":58},[],{"trials":249,"activeCount":58},[250],{"nctId":251,"briefTitle":252,"status":225,"phases":253,"primaryCompletion":254,"completion":254,"start":255,"enrollment":256,"conditions":257,"interventions":262},"NCT05924412","Parecoxib in Total Knee Arthroplasty",[50],"2024-09-01","2023-07-06",40,[15,258,29,259,260,261],"Pain, Acute","Analgesic Nephropathy","Analgesic Adverse Reaction","Knee Osteoarthritis",[238],{"trials":264,"activeCount":58},[],{"intervention":266,"totalTrials":54,"cells":267},"Dexmedetomidine-Dexamethasone",{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":272,"PHASE3":274,"PHASE4":276,"NA":289},{"trials":269,"activeCount":58},[],{"trials":271,"activeCount":58},[],{"trials":273,"activeCount":58},[],{"trials":275,"activeCount":58},[],{"trials":277,"activeCount":58},[278],{"nctId":279,"briefTitle":280,"status":225,"phases":281,"primaryCompletion":282,"completion":282,"start":283,"enrollment":284,"conditions":285,"interventions":287},"NCT04875039","Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks",[50],"2022-03-01","2021-08-31",50,[29,258,286],"Upper Extremity Injury",[288,266],"Dexamethasone",{"trials":290,"activeCount":58},[],{"intervention":292,"totalTrials":54,"cells":293},"CHOLESTYRAMINE",{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":298,"PHASE3":300,"PHASE4":302,"NA":315},{"trials":295,"activeCount":58},[],{"trials":297,"activeCount":58},[],{"trials":299,"activeCount":58},[],{"trials":301,"activeCount":58},[],{"trials":303,"activeCount":58},[304],{"nctId":305,"briefTitle":306,"status":225,"phases":307,"primaryCompletion":308,"completion":308,"start":309,"enrollment":19,"conditions":310,"interventions":314},"NCT02249897","PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs",[50],"2017-12","2015-01",[311,312,313],"DIABETES","DIABETIC RETINOPATHY","DIABETIC NEUROPATHY",[292],{"trials":316,"activeCount":58},[],{"intervention":318,"totalTrials":54,"cells":319},"Acetazolamide",{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":326,"PHASE4":328,"NA":340},{"trials":321,"activeCount":58},[],{"trials":323,"activeCount":58},[],{"trials":325,"activeCount":58},[],{"trials":327,"activeCount":58},[],{"trials":329,"activeCount":58},[330],{"nctId":331,"briefTitle":332,"status":225,"phases":333,"primaryCompletion":334,"completion":334,"start":335,"enrollment":284,"conditions":336,"interventions":339},"NCT02992938","Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia",[50],"2018-09-28","2016-12",[337,338],"Hyperalgesia","Opioid-Related Disorders",[318],{"trials":341,"activeCount":58},[],{"intervention":343,"totalTrials":54,"cells":344},"oral sildenafil",{"EARLY_PHASE1":345,"PHASE1":347,"PHASE2":349,"PHASE3":351,"PHASE4":353,"NA":365},{"trials":346,"activeCount":58},[],{"trials":348,"activeCount":58},[],{"trials":350,"activeCount":58},[],{"trials":352,"activeCount":58},[],{"trials":354,"activeCount":58},[355],{"nctId":356,"briefTitle":357,"status":141,"phases":358,"completion":359,"start":360,"enrollment":361,"conditions":362,"interventions":364},"NCT00483626","Hemodynamic Response After Six Months of Sildenafil",[50],"2007-06","2003-08",27,[363],"Pulmonary Arterial Hypertension",[343],{"trials":366,"activeCount":58},[],{"intervention":368,"totalTrials":54,"cells":369},"Same Bupivacaine Concentration",{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":378,"NA":392},{"trials":371,"activeCount":58},[],{"trials":373,"activeCount":58},[],{"trials":375,"activeCount":58},[],{"trials":377,"activeCount":58},[],{"trials":379,"activeCount":58},[380],{"nctId":381,"briefTitle":382,"status":383,"phases":384,"primaryCompletion":308,"completion":308,"start":385,"enrollment":386,"conditions":387,"interventions":390},"NCT02909257","Motor-Sparing Femoral Nerve Block Dose","TERMINATED",[50],"2016-09",31,[388,389],"Osteoarthritis, Knee","Knee Injuries",[368,391],"Lower Bupivacaine Concentration",{"trials":393,"activeCount":58},[],{"intervention":391,"totalTrials":54,"cells":395},{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":402,"PHASE4":404,"NA":410},{"trials":397,"activeCount":58},[],{"trials":399,"activeCount":58},[],{"trials":401,"activeCount":58},[],{"trials":403,"activeCount":58},[],{"trials":405,"activeCount":58},[406],{"nctId":381,"briefTitle":382,"status":383,"phases":407,"primaryCompletion":308,"completion":308,"start":385,"enrollment":386,"conditions":408,"interventions":409},[50],[388,389],[368,391],{"trials":411,"activeCount":58},[],{"intervention":413,"totalTrials":54,"cells":414},"Peroxide Carbamide 10% - Dental bleaching treatment",{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":421,"PHASE4":423,"NA":435},{"trials":416,"activeCount":58},[],{"trials":418,"activeCount":58},[],{"trials":420,"activeCount":58},[],{"trials":422,"activeCount":58},[],{"trials":424,"activeCount":58},[425],{"nctId":426,"briefTitle":427,"status":225,"phases":428,"primaryCompletion":429,"completion":429,"start":430,"enrollment":431,"conditions":432,"interventions":434},"NCT02017873","Longevity and Effectiveness of Bleaching in Healthy and Smokers Patients",[50],"2014-01","2013-12",120,[433],"Dentin Sensitivity",[413],{"trials":436,"activeCount":58},[],{"intervention":438,"totalTrials":54,"cells":439},"Bupivacaine Hydrochloride",{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":444,"PHASE3":446,"PHASE4":448,"NA":461},{"trials":441,"activeCount":58},[],{"trials":443,"activeCount":58},[],{"trials":445,"activeCount":58},[],{"trials":447,"activeCount":58},[],{"trials":449,"activeCount":58},[450],{"nctId":451,"briefTitle":452,"status":225,"phases":453,"primaryCompletion":454,"completion":455,"start":456,"enrollment":100,"conditions":457,"interventions":459},"NCT05359731","Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Blockade",[50],"2023-04-17","2023-04-24","2022-06-28",[29,458,286],"Acute Pain",[438,460],"Bupivacaine Hydrochloride with Dexamethasone",{"trials":462,"activeCount":58},[],{"intervention":460,"totalTrials":54,"cells":464},{"EARLY_PHASE1":465,"PHASE1":467,"PHASE2":469,"PHASE3":471,"PHASE4":473,"NA":479},{"trials":466,"activeCount":58},[],{"trials":468,"activeCount":58},[],{"trials":470,"activeCount":58},[],{"trials":472,"activeCount":58},[],{"trials":474,"activeCount":58},[475],{"nctId":451,"briefTitle":452,"status":225,"phases":476,"primaryCompletion":454,"completion":455,"start":456,"enrollment":100,"conditions":477,"interventions":478},[50],[29,458,286],[438,460],{"trials":480,"activeCount":58},[],{"intervention":482,"totalTrials":483,"cells":484},"Prednisone",2,{"EARLY_PHASE1":485,"PHASE1":487,"PHASE2":489,"PHASE3":491,"PHASE4":514,"NA":516},{"trials":486,"activeCount":58},[],{"trials":488,"activeCount":58},[],{"trials":490,"activeCount":58},[],{"trials":492,"activeCount":58},[493,504],{"nctId":494,"briefTitle":495,"status":141,"phases":496,"primaryCompletion":497,"completion":335,"start":498,"enrollment":499,"conditions":500,"interventions":503},"NCT02367118","Prednisone in Chronic Rhinosinusitis Without Nasal Polyps",[49],"2016-03","2015-06",90,[501,502],"Sinusitis","Chronic Rhinosinusitis",[482],{"nctId":505,"briefTitle":506,"status":383,"phases":507,"primaryCompletion":508,"completion":508,"start":509,"enrollment":510,"conditions":511,"interventions":513},"NCT04451174","Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia",[49],"2021-01-30","2020-06-23",60,[512],"COVID-19",[482],{"trials":515,"activeCount":58},[],{"trials":517,"activeCount":58},[],{"intervention":519,"totalTrials":54,"cells":520},"Creatine",{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":525,"PHASE3":527,"PHASE4":539,"NA":541},{"trials":522,"activeCount":58},[],{"trials":524,"activeCount":58},[],{"trials":526,"activeCount":58},[],{"trials":528,"activeCount":58},[529],{"nctId":530,"briefTitle":531,"status":225,"phases":532,"primaryCompletion":533,"completion":534,"start":535,"enrollment":284,"conditions":536,"interventions":538},"NCT02188849","Effects of Creatine Supplementation on Muscle Mass and Function Among Older Women Subjected to Resistance Training",[49],"2015-07","2015-08","2014-10",[537],"Muscle Weakness",[519],{"trials":540,"activeCount":58},[],{"trials":542,"activeCount":58},[],{"intervention":544,"totalTrials":54,"cells":545},"Biofreeze",{"EARLY_PHASE1":546,"PHASE1":548,"PHASE2":550,"PHASE3":552,"PHASE4":564,"NA":566},{"trials":547,"activeCount":58},[],{"trials":549,"activeCount":58},[],{"trials":551,"activeCount":58},[],{"trials":553,"activeCount":58},[554],{"nctId":555,"briefTitle":556,"status":557,"phases":558,"primaryCompletion":559,"completion":560,"start":561,"enrollment":58,"conditions":562,"interventions":563},"NCT01565070","Osteoarthritis in Older Adults: Recovery of Mobility and Pain With a Topical Analgesic","WITHDRAWN",[49],"2012-10","2012-12","2012-04",[261],[544],{"trials":565,"activeCount":58},[],{"trials":567,"activeCount":58},[],{"intervention":569,"totalTrials":54,"cells":570},"8% arginine\u002F1450ppm sodium monofluorophosphate dentifrice",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":587,"NA":589},{"trials":572,"activeCount":58},[],{"trials":574,"activeCount":58},[],{"trials":576,"activeCount":58},[],{"trials":578,"activeCount":58},[579],{"nctId":580,"briefTitle":581,"status":141,"phases":582,"primaryCompletion":385,"start":583,"enrollment":284,"conditions":584,"interventions":585},"NCT02829879","Effectiveness of Arginin and Potassium Nitrate Dentifrices in Dentin Hypersensitivity Therapy",[49],"2015-12",[433],[569,586],"5% potassium nitrate\u002F2500ppm sodium fluoride dentifrice",{"trials":588,"activeCount":58},[],{"trials":590,"activeCount":58},[],{"intervention":586,"totalTrials":54,"cells":592},{"EARLY_PHASE1":593,"PHASE1":595,"PHASE2":597,"PHASE3":599,"PHASE4":605,"NA":607},{"trials":594,"activeCount":58},[],{"trials":596,"activeCount":58},[],{"trials":598,"activeCount":58},[],{"trials":600,"activeCount":58},[601],{"nctId":580,"briefTitle":581,"status":141,"phases":602,"primaryCompletion":385,"start":583,"enrollment":284,"conditions":603,"interventions":604},[49],[433],[569,586],{"trials":606,"activeCount":58},[],{"trials":608,"activeCount":58},[],{"intervention":610,"totalTrials":54,"cells":611},"ROTAVAC 5D",{"EARLY_PHASE1":612,"PHASE1":614,"PHASE2":616,"PHASE3":618,"PHASE4":629,"NA":631},{"trials":613,"activeCount":58},[],{"trials":615,"activeCount":58},[],{"trials":617,"activeCount":58},[],{"trials":619,"activeCount":58},[620],{"nctId":621,"briefTitle":622,"status":141,"phases":623,"primaryCompletion":624,"completion":624,"start":255,"enrollment":625,"conditions":626,"interventions":628},"NCT05958771","The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E",[49],"2025-06-01",5800,[627],"Rotavirus Gastroenteritis",[610],{"trials":630,"activeCount":58},[],{"trials":632,"activeCount":58},[],{"intervention":634,"totalTrials":54,"cells":635},"Allogenic stromal mesenchymal cells derived from the umbilical cord",{"EARLY_PHASE1":636,"PHASE1":638,"PHASE2":640,"PHASE3":642,"PHASE4":655,"NA":657},{"trials":637,"activeCount":58},[],{"trials":639,"activeCount":58},[],{"trials":641,"activeCount":58},[],{"trials":643,"activeCount":58},[644],{"nctId":645,"briefTitle":646,"status":141,"phases":647,"primaryCompletion":648,"completion":649,"start":650,"enrollment":651,"conditions":652,"interventions":654},"NCT03905824","The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus",[49],"2020-12-31","2024-12-31","2019-01-15",70,[653],"Osteochondral Fracture of Talus",[634],{"trials":656,"activeCount":58},[],{"trials":658,"activeCount":58},[],{"intervention":660,"totalTrials":54,"cells":661},"Gonyautoxin",{"EARLY_PHASE1":662,"PHASE1":664,"PHASE2":666,"PHASE3":677,"PHASE4":679,"NA":681},{"trials":663,"activeCount":58},[],{"trials":665,"activeCount":58},[],{"trials":667,"activeCount":58},[668],{"nctId":669,"briefTitle":670,"status":383,"phases":671,"completion":672,"start":673,"enrollment":361,"conditions":674,"interventions":676},"NCT00276952","Gonyautoxin in the Treatment of Chronic Tension-Type Headache",[48],"2005-08","2004-09",[675],"Tension-Type Headache",[660],{"trials":678,"activeCount":58},[],{"trials":680,"activeCount":58},[],{"trials":682,"activeCount":58},[],{"intervention":684,"totalTrials":54,"cells":685},"Azithromycin",{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":700,"PHASE4":702,"NA":704},{"trials":687,"activeCount":58},[],{"trials":689,"activeCount":58},[],{"trials":691,"activeCount":58},[692],{"nctId":693,"briefTitle":694,"status":141,"phases":695,"primaryCompletion":335,"completion":696,"start":498,"enrollment":697,"conditions":698,"interventions":699},"NCT02839408","Efficacy of Oral Probiotic and Antibiotic Administration in Patients With Chronic Periodontitis",[48],"2017-03",54,[232],[684],{"trials":701,"activeCount":58},[],{"trials":703,"activeCount":58},[],{"trials":705,"activeCount":58},[],{"intervention":707,"totalTrials":54,"cells":708},"MU001 patches",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":725,"PHASE4":727,"NA":729},{"trials":710,"activeCount":58},[],{"trials":712,"activeCount":58},[],{"trials":714,"activeCount":58},[715],{"nctId":716,"briefTitle":717,"status":141,"phases":718,"primaryCompletion":719,"completion":720,"start":721,"enrollment":499,"conditions":722,"interventions":724},"NCT03166423","Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers",[47,48],"2017-06-01","2017-07-01","2015-11-12",[723],"Diabetic Foot Ulcer",[707],{"trials":726,"activeCount":58},[],{"trials":728,"activeCount":58},[],{"trials":730,"activeCount":58},[],{"intervention":732,"totalTrials":54,"cells":733},"TAPCells vaccine",{"EARLY_PHASE1":734,"PHASE1":736,"PHASE2":738,"PHASE3":750,"PHASE4":752,"NA":754},{"trials":735,"activeCount":58},[],{"trials":737,"activeCount":58},[],{"trials":739,"activeCount":58},[740],{"nctId":741,"briefTitle":742,"status":225,"phases":743,"primaryCompletion":744,"completion":744,"start":745,"enrollment":499,"conditions":746,"interventions":749},"NCT06152367","Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients",[47,48],"2004-10-09","2001-01-30",[747,748],"Stage III Malignant Melanoma of Skin AJCC V6","Stage IV Malignant Melanoma of Skin",[732],{"trials":751,"activeCount":58},[],{"trials":753,"activeCount":58},[],{"trials":755,"activeCount":58},[],{"intervention":757,"totalTrials":54,"cells":758},"Nicotinamide",{"EARLY_PHASE1":759,"PHASE1":761,"PHASE2":763,"PHASE3":778,"PHASE4":780,"NA":782},{"trials":760,"activeCount":58},[],{"trials":762,"activeCount":58},[],{"trials":764,"activeCount":58},[765],{"nctId":766,"briefTitle":767,"status":141,"phases":768,"primaryCompletion":769,"completion":770,"start":771,"enrollment":510,"conditions":772,"interventions":777},"NCT06465602","Nicotinamide Supplementation Improves Physical Performance in Older Adults at Risk of Falls",[48],"2024-11-30","2025-02-28","2024-05-21",[773,774,775,776],"Frailty","Fall","Frailty Syndrome","Falls",[757],{"trials":779,"activeCount":58},[],{"trials":781,"activeCount":58},[],{"trials":783,"activeCount":58},[],{"intervention":785,"totalTrials":54,"cells":786},"Autologous serum - Systane",{"EARLY_PHASE1":787,"PHASE1":789,"PHASE2":791,"PHASE3":803,"PHASE4":805,"NA":807},{"trials":788,"activeCount":58},[],{"trials":790,"activeCount":58},[],{"trials":792,"activeCount":58},[793],{"nctId":794,"briefTitle":795,"status":225,"phases":796,"primaryCompletion":797,"completion":797,"start":798,"enrollment":9,"conditions":799,"interventions":801},"NCT00779987","Autologous Serum Efficacy Study in Patients With Severe Dry Eye",[48],"2008-12","2008-10",[800],"Dry Eye",[785,802],"Systane - Autologous serum",{"trials":804,"activeCount":58},[],{"trials":806,"activeCount":58},[],{"trials":808,"activeCount":58},[],{"intervention":802,"totalTrials":54,"cells":810},{"EARLY_PHASE1":811,"PHASE1":813,"PHASE2":815,"PHASE3":821,"PHASE4":823,"NA":825},{"trials":812,"activeCount":58},[],{"trials":814,"activeCount":58},[],{"trials":816,"activeCount":58},[817],{"nctId":794,"briefTitle":795,"status":225,"phases":818,"primaryCompletion":797,"completion":797,"start":798,"enrollment":9,"conditions":819,"interventions":820},[48],[800],[785,802],{"trials":822,"activeCount":58},[],{"trials":824,"activeCount":58},[],{"trials":826,"activeCount":58},[],{"intervention":828,"totalTrials":54,"cells":829},"Dentoxol mouthrinse dosages",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":848,"PHASE4":850,"NA":852},{"trials":831,"activeCount":58},[],{"trials":833,"activeCount":58},[],{"trials":835,"activeCount":58},[836],{"nctId":837,"briefTitle":838,"status":141,"phases":839,"primaryCompletion":840,"completion":841,"start":842,"enrollment":843,"conditions":844,"interventions":847},"NCT05288478","Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.",[48],"2022-08","2023-03","2022-04-06",100,[845,846],"Epidermolysis Bullosa","Oral Ulcer",[828],{"trials":849,"activeCount":58},[],{"trials":851,"activeCount":58},[],{"trials":853,"activeCount":58},[],{"intervention":855,"totalTrials":54,"cells":856},"TRIMELVAX",{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":872,"PHASE3":874,"PHASE4":876,"NA":878},{"trials":858,"activeCount":58},[],{"trials":860,"activeCount":58},[861],{"nctId":862,"briefTitle":863,"status":141,"phases":864,"primaryCompletion":865,"completion":866,"start":867,"enrollment":100,"conditions":868,"interventions":871},"NCT06556004","Phase 1 Study Using TRIMELVax for Stage IIIC \u002F IV Melanoma Patients",[47],"2023-12-31","2025-03-31","2021-05-02",[869,870],"Melanoma Stage IIIc","Melanoma Stage IV",[855],{"trials":873,"activeCount":58},[],{"trials":875,"activeCount":58},[],{"trials":877,"activeCount":58},[],{"trials":879,"activeCount":58},[],{"intervention":881,"totalTrials":54,"cells":882},"Antioxidant therapy",{"EARLY_PHASE1":883,"PHASE1":885,"PHASE2":903,"PHASE3":905,"PHASE4":907,"NA":909},{"trials":884,"activeCount":58},[],{"trials":886,"activeCount":58},[887],{"nctId":888,"briefTitle":889,"status":225,"phases":890,"primaryCompletion":891,"completion":892,"start":893,"enrollment":894,"conditions":895,"interventions":901},"NCT05215743","Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.",[47],"2022-11-22","2022-12-22","2022-08-09",18,[896,897,898,899,900],"Acute Myocardial Infarction","Ischemia-reperfusion Injury","Reperfusion Injury, Myocardial","Reperfusion Arrhythmias","Reperfusion Injury",[881,902],"NaCl 0.9%",{"trials":904,"activeCount":58},[],{"trials":906,"activeCount":58},[],{"trials":908,"activeCount":58},[],{"trials":910,"activeCount":58},[],{"intervention":902,"totalTrials":54,"cells":912},{"EARLY_PHASE1":913,"PHASE1":915,"PHASE2":921,"PHASE3":923,"PHASE4":925,"NA":927},{"trials":914,"activeCount":58},[],{"trials":916,"activeCount":58},[917],{"nctId":888,"briefTitle":889,"status":225,"phases":918,"primaryCompletion":891,"completion":892,"start":893,"enrollment":894,"conditions":919,"interventions":920},[47],[896,897,898,899,900],[881,902],{"trials":922,"activeCount":58},[],{"trials":924,"activeCount":58},[],{"trials":926,"activeCount":58},[],{"trials":928,"activeCount":58},[],{"intervention":930,"totalTrials":54,"cells":931},"Neosaxitoxin",{"EARLY_PHASE1":932,"PHASE1":934,"PHASE2":946,"PHASE3":948,"PHASE4":950,"NA":952},{"trials":933,"activeCount":58},[],{"trials":935,"activeCount":58},[936],{"nctId":937,"briefTitle":938,"status":225,"phases":939,"completion":940,"start":941,"enrollment":942,"conditions":943,"interventions":945},"NCT00273065","Local Anesthetic Properties of Neosaxitoxin",[47],"2005-09","2005-05",10,[944],"Healthy Volunteers",[930],{"trials":947,"activeCount":58},[],{"trials":949,"activeCount":58},[],{"trials":951,"activeCount":58},[],{"trials":953,"activeCount":58},[],{"intervention":288,"totalTrials":483,"cells":955},{"EARLY_PHASE1":956,"PHASE1":958,"PHASE2":960,"PHASE3":962,"PHASE4":964,"NA":970},{"trials":957,"activeCount":58},[],{"trials":959,"activeCount":58},[],{"trials":961,"activeCount":58},[],{"trials":963,"activeCount":58},[],{"trials":965,"activeCount":58},[966],{"nctId":279,"briefTitle":280,"status":225,"phases":967,"primaryCompletion":282,"completion":282,"start":283,"enrollment":284,"conditions":968,"interventions":969},[50],[29,258,286],[288,266],{"trials":971,"activeCount":58},[972],{"nctId":973,"briefTitle":974,"status":225,"phases":975,"primaryCompletion":976,"completion":976,"start":977,"enrollment":431,"conditions":978,"interventions":979},"NCT03610893","Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks",[51],"2019-04-30","2018-08-16",[15,258,286],[288,980],"Dexmedetomidine",{"intervention":982,"totalTrials":483,"cells":983},"Sevoflurane",{"EARLY_PHASE1":984,"PHASE1":986,"PHASE2":988,"PHASE3":990,"PHASE4":992,"NA":994},{"trials":985,"activeCount":58},[],{"trials":987,"activeCount":58},[],{"trials":989,"activeCount":58},[],{"trials":991,"activeCount":58},[],{"trials":993,"activeCount":58},[],{"trials":995,"activeCount":58},[996,1007],{"nctId":997,"briefTitle":998,"status":225,"phases":999,"primaryCompletion":1000,"completion":1000,"start":1001,"enrollment":1002,"conditions":1003,"interventions":1005},"NCT03772054","Sevoflurane vs Propofol Effect on Endothelial Damage Markers After Knee Ligament Surgery.",[51],"2019-12-11","2018-12-20",16,[1004],"Ischemia Reperfusion Injury",[982,1006],"Propofol",{"nctId":1008,"briefTitle":1009,"status":225,"phases":1010,"primaryCompletion":1011,"completion":1012,"start":1013,"enrollment":1014,"conditions":1015,"interventions":1018},"NCT04188782","Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure",[],"2021-08-20","2021-09-22","2019-11-20",24,[1016,1017],"Anesthesia","Tolerance",[982],{"intervention":1006,"totalTrials":483,"cells":1020},{"EARLY_PHASE1":1021,"PHASE1":1023,"PHASE2":1025,"PHASE3":1027,"PHASE4":1029,"NA":1041},{"trials":1022,"activeCount":58},[],{"trials":1024,"activeCount":58},[],{"trials":1026,"activeCount":58},[],{"trials":1028,"activeCount":58},[],{"trials":1030,"activeCount":58},[1031],{"nctId":1032,"briefTitle":1033,"status":225,"phases":1034,"primaryCompletion":1035,"completion":1035,"start":977,"enrollment":1036,"conditions":1037,"interventions":1040},"NCT04345926","Dose-response Curves Between Propofol and Intraoperative Electroencephalographic Patterns",[50],"2020-02-26",15,[1038,1039],"Propofol Overdose","EEG",[1006],{"trials":1042,"activeCount":58},[1043],{"nctId":997,"briefTitle":998,"status":225,"phases":1044,"primaryCompletion":1000,"completion":1000,"start":1001,"enrollment":1002,"conditions":1045,"interventions":1046},[51],[1004],[982,1006],{"intervention":1048,"totalTrials":54,"cells":1049},"peroxide gel tooth bleaching 6%",{"EARLY_PHASE1":1050,"PHASE1":1052,"PHASE2":1054,"PHASE3":1056,"PHASE4":1058,"NA":1060},{"trials":1051,"activeCount":58},[],{"trials":1053,"activeCount":58},[],{"trials":1055,"activeCount":58},[],{"trials":1057,"activeCount":58},[],{"trials":1059,"activeCount":58},[],{"trials":1061,"activeCount":58},[1062],{"nctId":1063,"briefTitle":1064,"status":225,"phases":1065,"primaryCompletion":1066,"completion":1067,"start":1068,"enrollment":386,"conditions":1069,"interventions":1071},"NCT02603354","Efectiveness of a Brief Protocol by a Low (6%) Concentration Gel Peroxide Hydrogen of Teeth Bleaching",[51],"2015-04","2015-10","2015-03",[1070],"Tooth Discoloration",[1048],{"intervention":1073,"totalTrials":54,"cells":1074},"Saline",{"EARLY_PHASE1":1075,"PHASE1":1077,"PHASE2":1079,"PHASE3":1081,"PHASE4":1083,"NA":1085},{"trials":1076,"activeCount":58},[],{"trials":1078,"activeCount":58},[],{"trials":1080,"activeCount":58},[],{"trials":1082,"activeCount":58},[],{"trials":1084,"activeCount":58},[],{"trials":1086,"activeCount":58},[1087],{"nctId":1088,"briefTitle":1089,"status":225,"phases":1090,"primaryCompletion":1091,"completion":1091,"start":498,"enrollment":1092,"conditions":1093,"interventions":1094},"NCT02450214","Intraoperative Ketamine and Magnesium Therapy for Control of Postoperative Pain After a Liposuction and Lipoabdominoplasty",[51],"2017-07",63,[15],[1073,1095,1096],"Ketamine","Ketamine + magnesium",{"intervention":1095,"totalTrials":54,"cells":1098},{"EARLY_PHASE1":1099,"PHASE1":1101,"PHASE2":1103,"PHASE3":1105,"PHASE4":1107,"NA":1109},{"trials":1100,"activeCount":58},[],{"trials":1102,"activeCount":58},[],{"trials":1104,"activeCount":58},[],{"trials":1106,"activeCount":58},[],{"trials":1108,"activeCount":58},[],{"trials":1110,"activeCount":58},[1111],{"nctId":1088,"briefTitle":1089,"status":225,"phases":1112,"primaryCompletion":1091,"completion":1091,"start":498,"enrollment":1092,"conditions":1113,"interventions":1114},[51],[15],[1073,1095,1096],{"intervention":1096,"totalTrials":54,"cells":1116},{"EARLY_PHASE1":1117,"PHASE1":1119,"PHASE2":1121,"PHASE3":1123,"PHASE4":1125,"NA":1127},{"trials":1118,"activeCount":58},[],{"trials":1120,"activeCount":58},[],{"trials":1122,"activeCount":58},[],{"trials":1124,"activeCount":58},[],{"trials":1126,"activeCount":58},[],{"trials":1128,"activeCount":58},[1129],{"nctId":1088,"briefTitle":1089,"status":225,"phases":1130,"primaryCompletion":1091,"completion":1091,"start":498,"enrollment":1092,"conditions":1131,"interventions":1132},[51],[15],[1073,1095,1096],{"intervention":1134,"totalTrials":54,"cells":1135},"Deep sedation with propofol andfentanyl",{"EARLY_PHASE1":1136,"PHASE1":1138,"PHASE2":1140,"PHASE3":1142,"PHASE4":1144,"NA":1146},{"trials":1137,"activeCount":58},[],{"trials":1139,"activeCount":58},[],{"trials":1141,"activeCount":58},[],{"trials":1143,"activeCount":58},[],{"trials":1145,"activeCount":58},[],{"trials":1147,"activeCount":58},[1148],{"nctId":1149,"briefTitle":1150,"status":557,"phases":1151,"primaryCompletion":1152,"completion":1152,"start":1153,"enrollment":58,"conditions":1154,"interventions":1157},"NCT04026451","Spectral Edge Frequency From Spectral EEG Analysis to Guide Deep Sedation in the Critical Care Setting (Pilot)",[51],"2021-04-01","2019-11-11",[1155,1156],"Deep Sedation","Mechanical Ventilation",[1134],{"intervention":1159,"totalTrials":54,"cells":1160},"gel HP",{"EARLY_PHASE1":1161,"PHASE1":1163,"PHASE2":1165,"PHASE3":1167,"PHASE4":1169,"NA":1171},{"trials":1162,"activeCount":58},[],{"trials":1164,"activeCount":58},[],{"trials":1166,"activeCount":58},[],{"trials":1168,"activeCount":58},[],{"trials":1170,"activeCount":58},[],{"trials":1172,"activeCount":58},[1173],{"nctId":1174,"briefTitle":1175,"status":225,"phases":1176,"primaryCompletion":1177,"completion":1177,"start":1178,"enrollment":1179,"conditions":1180,"interventions":1181},"NCT03217994","Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent",[51],"2016-12-31","2015-01-01",33,[1070],[1159],{"intervention":980,"totalTrials":54,"cells":1183},{"EARLY_PHASE1":1184,"PHASE1":1186,"PHASE2":1188,"PHASE3":1190,"PHASE4":1192,"NA":1194},{"trials":1185,"activeCount":58},[],{"trials":1187,"activeCount":58},[],{"trials":1189,"activeCount":58},[],{"trials":1191,"activeCount":58},[],{"trials":1193,"activeCount":58},[],{"trials":1195,"activeCount":58},[1196],{"nctId":973,"briefTitle":974,"status":225,"phases":1197,"primaryCompletion":976,"completion":976,"start":977,"enrollment":431,"conditions":1198,"interventions":1199},[51],[15,258,286],[288,980],{"intervention":1201,"totalTrials":54,"cells":1202},"Bleaching teeth",{"EARLY_PHASE1":1203,"PHASE1":1205,"PHASE2":1207,"PHASE3":1209,"PHASE4":1211,"NA":1213},{"trials":1204,"activeCount":58},[],{"trials":1206,"activeCount":58},[],{"trials":1208,"activeCount":58},[],{"trials":1210,"activeCount":58},[],{"trials":1212,"activeCount":58},[],{"trials":1214,"activeCount":58},[1215],{"nctId":1216,"briefTitle":1217,"status":225,"phases":1218,"primaryCompletion":430,"completion":1067,"start":1219,"enrollment":1220,"conditions":1221,"interventions":1222},"NCT02605239","Phycosocial Impact of Bleaching Teeth",[51],"2013-03",58,[1070],[1201],{"intervention":1224,"totalTrials":54,"cells":1225},"Bupivacaine",{"EARLY_PHASE1":1226,"PHASE1":1228,"PHASE2":1230,"PHASE3":1232,"PHASE4":1234,"NA":1236},{"trials":1227,"activeCount":58},[],{"trials":1229,"activeCount":58},[],{"trials":1231,"activeCount":58},[],{"trials":1233,"activeCount":58},[],{"trials":1235,"activeCount":58},[],{"trials":1237,"activeCount":58},[1238],{"nctId":1239,"briefTitle":1240,"status":141,"phases":1241,"primaryCompletion":1242,"completion":1243,"start":1244,"enrollment":1245,"conditions":1246,"interventions":1248},"NCT05068063","Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia",[51],"2022-09-30","2022-10-15","2022-06-01",48,[1247,458,15,389],"Anterior Cruciate Ligament Rupture",[1224,1249],"normal Saline",{"intervention":1249,"totalTrials":54,"cells":1251},{"EARLY_PHASE1":1252,"PHASE1":1254,"PHASE2":1256,"PHASE3":1258,"PHASE4":1260,"NA":1262},{"trials":1253,"activeCount":58},[],{"trials":1255,"activeCount":58},[],{"trials":1257,"activeCount":58},[],{"trials":1259,"activeCount":58},[],{"trials":1261,"activeCount":58},[],{"trials":1263,"activeCount":58},[1264],{"nctId":1239,"briefTitle":1240,"status":141,"phases":1265,"primaryCompletion":1242,"completion":1243,"start":1244,"enrollment":1245,"conditions":1266,"interventions":1267},[51],[1247,458,15,389],[1224,1249],{"intervention":1269,"totalTrials":54,"cells":1270},"Recombinant EPO",{"EARLY_PHASE1":1271,"PHASE1":1273,"PHASE2":1275,"PHASE3":1277,"PHASE4":1279,"NA":1281},{"trials":1272,"activeCount":58},[],{"trials":1274,"activeCount":58},[],{"trials":1276,"activeCount":58},[],{"trials":1278,"activeCount":58},[],{"trials":1280,"activeCount":58},[],{"trials":1282,"activeCount":58},[1283],{"nctId":1284,"briefTitle":1285,"status":225,"phases":1286,"primaryCompletion":1287,"completion":1288,"start":1289,"enrollment":510,"conditions":1290,"interventions":1293},"NCT03803514","Effect of rEPO in FGF23 in ESRD Patients",[],"2019-03-31","2019-10-20","2017-08-15",[1291,1292],"Anemia","Chronic Kidney Diseases",[1269]]